<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00856453</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000632845</org_study_id>
    <secondary_id>CCCWFU-98408</secondary_id>
    <secondary_id>IRB00007745</secondary_id>
    <nct_id>NCT00856453</nct_id>
  </id_info>
  <brief_title>Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer</brief_title>
  <official_title>Restorative Yoga for Women With Ovarian Cancer Undergoing Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Yoga may decrease fatigue, distress, and depression, and improve sleep quality in&#xD;
      patients undergoing chemotherapy for ovarian cancer. It is not yet known whether practicing&#xD;
      yoga in group classes is more effective than practicing yoga at home.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial is studying how well yoga works in relieving fatigue&#xD;
      in patients undergoing chemotherapy for ovarian cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Primary&#xD;
&#xD;
        -  Examine the effectiveness of a restorative yoga (RY) intervention vs home yoga practice&#xD;
           in patients undergoing chemotherapy for ovarian cancer.&#xD;
&#xD;
      Secondary&#xD;
&#xD;
        -  Examine the effectiveness of RY vs home yoga practice on depression, distress, and sleep&#xD;
           quality in these patients.&#xD;
&#xD;
        -  Examine the acute (pre- and post-yoga class) effects in these patients.&#xD;
&#xD;
        -  Test the feasibility of using behavioral strategies to enhance yoga intervention&#xD;
           adherence.&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 2 arms.&#xD;
&#xD;
        -  Arm I (restorative yoga intervention): Patients attend 45-minute group yoga classes&#xD;
           every 3 weeks on the days they are scheduled for chemotherapy for approximately 5-6&#xD;
           sessions. Patients are provided with a yoga DVD, a manual with photos and written&#xD;
           descriptions/guidance to practice yoga postures at home, and basic yoga equipment (yoga&#xD;
           mat, strap, block, yoga blankets) and instructed to practice to the DVD 3 times per week&#xD;
           (twice weekly during week of group yoga class) for ≥ 45 minutes. Patients record yoga&#xD;
           practice time/activity at the third yoga session of each week.&#xD;
&#xD;
        -  Arm II (home yoga practice): Patients are provided with a yoga DVD, a manual with photos&#xD;
           and written descriptions/guidance to practice yoga postures at home, and basic yoga&#xD;
           equipment (yoga mat, strap, block, yoga blankets) and instructed to practice to the DVD&#xD;
           3 times per week for ≥ 45 minutes. Patients record yoga practice time/activity at the&#xD;
           third yoga session of each week.&#xD;
&#xD;
      All patients complete questionnaires at baseline, at weeks 9, 18, and 22. Self-report&#xD;
      measures include Distress Thermometer, Positive and Negative Affect Schedule, Center for&#xD;
      Epidemiologic Studies-Depression Scale, M.D. Anderson Symptom Inventory, Functional&#xD;
      Assessment of Cancer Therapy - Ovarian, Functional Assessment of Chronic Illness Therapy&#xD;
      (FACIT) - Spiritual Subscale, FACIT- Fatigue Subscale, State-Trait Anxiety Inventory, Women's&#xD;
      Health Initiative Insomnia Rating Scale, Medical Outcome Study-Social Support Survey,&#xD;
      Integrative Medicine Use, Pre- and Post- Class Ratings, and Intervention Feedback .&#xD;
&#xD;
      After completion of study, patients are followed at 4 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    slow accrual&#xD;
  </why_stopped>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported fatigue</measure>
    <time_frame>22 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported distress, depression, and sleep quality</measure>
    <time_frame>22 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre- and post-yoga class change in symptom/distress ratings</measure>
    <time_frame>22 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yoga intervention adherence</measure>
    <time_frame>18 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Depression</condition>
  <condition>Fatigue</condition>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Yoga classes plus home yoga practic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>home yoga practice alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home yoga practice</intervention_name>
    <description>training for and tracking of patient's practice of yoga at home</description>
    <arm_group_label>Yoga classes plus home yoga practic</arm_group_label>
    <arm_group_label>home yoga practice alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>yoga classes</intervention_name>
    <description>organized out of home classes for yoga</description>
    <arm_group_label>Yoga classes plus home yoga practic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Diagnosis of ovarian cancer&#xD;
&#xD;
               -  Any stage disease&#xD;
&#xD;
          -  Must be between 2-24 months post-primary treatment (surgery) following initial&#xD;
             diagnosis and/or have a recurrence of ovarian cancer within the past 24 months&#xD;
             (irrespective of current treatment status)&#xD;
&#xD;
          -  Began a new chemotherapy treatment regimen within the past 4 weeks or planning to&#xD;
             begin new chemotherapy treatment regimen within the next 4 weeks&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  ECOG performance status 0-2&#xD;
&#xD;
          -  Physically able to attend the intervention classes&#xD;
&#xD;
          -  Able to understand written and spoken English&#xD;
&#xD;
          -  Agree to keep psychiatric medications and doses stable during study intervention&#xD;
&#xD;
          -  No medical contraindications reported by the attending physician&#xD;
&#xD;
          -  No bipolar disorder, schizophrenia, psychotic depression, or any other psychotic&#xD;
             disorder&#xD;
&#xD;
          -  No usage of illicit drugs&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
&#xD;
          -  More than 3 months since prior yoga practice&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne C. Danhauer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brigitte E. Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Comprehensive Cancer Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157-1096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>March 4, 2009</study_first_submitted>
  <study_first_submitted_qc>March 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2009</study_first_posted>
  <last_update_submitted>August 7, 2018</last_update_submitted>
  <last_update_submitted_qc>August 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fatigue</keyword>
  <keyword>depression</keyword>
  <keyword>recurrent ovarian epithelial cancer</keyword>
  <keyword>recurrent ovarian germ cell tumor</keyword>
  <keyword>stage I ovarian epithelial cancer</keyword>
  <keyword>stage I ovarian germ cell tumor</keyword>
  <keyword>stage II ovarian epithelial cancer</keyword>
  <keyword>stage II ovarian germ cell tumor</keyword>
  <keyword>stage III ovarian epithelial cancer</keyword>
  <keyword>stage III ovarian germ cell tumor</keyword>
  <keyword>stage IV ovarian epithelial cancer</keyword>
  <keyword>stage IV ovarian germ cell tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

